Search results for "death"

showing 10 items of 1744 documents

Parkinson's disease and cancer: insights for pathogenesis from epidemiology .

2009

Epidemiological evidence suggests a reduced incidence of many common types of cancers in individuals with Parkinson's disease (PD). Parkinson's disease and cancer are two diseases that result from an excessive signaling by one of two forces driving cells to opposite directions. PD results from the excessive death of dopaminergic neurons in the substantia nigra pars compacta (SNc) in the brain, while uncontrolled growth is the key property of cancer. Parkinson's disease is a complex disorder, probably due in most of the cases to the interaction of environment and genes. Many genes responsible for familial forms of PD are supposed to have a supportive role in regulating or maintaining the cel…

Parkinson's diseaseCell Deathbusiness.industryPars compactaGeneral NeuroscienceIncidenceDopaminergicCancerSubstantia nigraParkinson DiseaseDiseaseCell cyclemedicine.disease_causemedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologySubstantia NigraHistory and Philosophy of ScienceRisk FactorsNeoplasmsMedicineHumansbusinessCarcinogenesisNeuroscienceAnnals of the New York Academy of Sciences
researchProduct

Small Extracellular Vesicles Secreted by Region-specific Astrocytes Ameliorate the Mitochondrial Function in a Cellular Model of Parkinson’s Disease

2021

AbstractExtracellular vesicles (EVs) are emerging as powerful players in cell-to-cell communication both in health and diseased brain. In Parkinson’s disease (PD) – characterized by selective dopaminergic (DAergic) neuron death in ventral midbrain (VMB) and degeneration of DAergic terminals in striatum (STR) – astrocytes (AS) exert dual harmful/protective functions. When activated by chemokine CCL3, AS promote a robust DAergic neuroprotection both in cellular and pre-clinical models of PD, with mechanisms not fully elucidated. Here we used a combination of techniques to characterize AS-EVs derived from VMB and STR, and investigated their potential to exert neuroprotection. First, we show th…

Parkinson's diseaseChemistryDopaminergicmedicineSecretionStriatumCellular modelmedicine.disease_causeNeuron deathmedicine.diseaseNeuroprotectionOxidative stressCell biology
researchProduct

Parthenolide induces caspase-independent and AIF mediated cell death in tumor cells

2012

Parthenolide caspase-independent cell death. AIF tumor cells
researchProduct

“Super p53” Mice Display Retinal Astroglial Changes

2013

Tumour-suppressor genes, such as the p53 gene, produce proteins that inhibit cell division under adverse conditions, as in the case of DNA damage, radiation, hypoxia, or oxidative stress (OS). The p53 gene can arrest proliferation and trigger death by apoptosis subsequent to several factors. In astrocytes, p53 promotes cell-cycle arrest and is involved in oxidative stress-mediated astrocyte cell death. Increasingly, astrocytic p53 is proving fundamental in orchestrating neurodegenerative disease pathogenesis. In terms of ocular disease, p53 may play a role in hypoxia due to ischaemia and may be involved in the retinal response to oxidative stress (OS). We studied the influence of the p53 ge…

PathologyAnatomy and PhysiologyCell divisionMouselcsh:MedicineFluorescent Antibody Techniquemedicine.disease_causechemistry.chemical_compoundMiceMolecular Cell Biologylcsh:ScienceMultidisciplinaryGlial fibrillary acidic proteinAnimal ModelsCell biologymedicine.anatomical_structureMedicineOftalmologíaDNA modificationAstrocyteResearch ArticleSignal TransductionProgrammed cell deathmedicine.medical_specialtyCell PhysiologyHistologyOcular AnatomyNeurocienciasMice TransgenicBiologyRetinaModel OrganismsOcular SystemGlial Fibrillary Acidic ProteinmedicineGeneticsAnimalsBiologyRetinaStaining and Labelinglcsh:RRetinalAnatomía ocularMice Inbred C57BLGenética médicaOphthalmologychemistryApoptosisAstrocytesbiology.proteinlcsh:QGene expressionGene FunctionTumor Suppressor Protein p53Animal GeneticsOxidative stress
researchProduct

Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34⁺ cells in a xenograft model

2012

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), delivered as a membrane-bound molecule expressed on the surface of adenovirus-transduced CD34+ cells (CD34-TRAIL+), was analyzed for its apoptotic activity in vitro on 12 breast cancer cell lines representing estrogen receptor-positive, HER2+ and triple-negative (TN) subtypes and for its effect on tumor growth, vascularization, necrosis, and lung metastasis incidence in NOD/SCID mice xenografted with the TN breast cancer line MDA-MB-231. Mesenchymal TN cell lines, which are the richest in putative tumor stem cells among the different breast cancer cell subtypes, were the most susceptible to apoptosis induced by CD34-TRAIL+ cel…

PathologyCancer ResearchCD34Antigens CD34ApoptosisMice SCIDMetastasisMetastasisTNF-Related Apoptosis-Inducing LigandMicePreclinical StudyMice Inbred NODNeoplasm Metastasisskin and connective tissue diseasesHeterologousTumorbiologyCell DeathCancer stem cellsTumor BurdenOncologyNeoplastic Stem CellsTumor necrosis factor alphaFemalemedicine.medical_specialtyTRAIL BREAST CANCERTransplantation HeterologousBreast NeoplasmsSCIDCell LineTriple-negative breast cancerCancer stem cellCell Line TumormedicineAnimalsHumansAntigensTransplantationCD44Mesenchymal stem cellmedicine.diseaseApoptosisCell culturebiology.proteinCancer researchInbred NODCD34Settore MED/36 - Diagnostica Per Immagini E RadioterapiaAnimals; Antigens CD34; Apoptosis; Breast Neoplasms; Cell Death; Cell Line Tumor; Female; Humans; Mice; Mice Inbred NOD; Mice SCID; Neoplasm Metastasis; Neoplastic Stem Cells; TNF-Related Apoptosis-Inducing Ligand; Transplantation Heterologous; Tumor BurdenmTRAIL
researchProduct

Immunohistochemical detection of early myocardial infarction: a systematic review

2017

The postmortem diagnosis of early myocardial infarction is a challenge for forensic pathologists because the routine histology is neither specific. Many authors have suggested the use of the immunohistochemistry to fill the gaps in the histological diagnosis of early myocardial infarction. This review aims to analyse advances of immunohistochemical detection of early cardiac damage due to ischaemia. To this purpose, we reviewed experimental studies that investigated immunohistochemical markers and their estimated timing of expression. The review was performed according to specific inclusion and exclusion criteria, and a total of 23 studies assessing the immunohistochemical markers for the d…

Pathologymedicine.medical_specialty2734Myocardial InfarctionIschemia030204 cardiovascular system & hematologyPathology and Forensic MedicineSudden cardiac death03 medical and health sciences0302 clinical medicineSettore MED/43 - Medicina LegaleHistological diagnosisEarly myocardial infarctionmedicineAnimalsHumans030216 legal & forensic medicineMyocardial infarctionEarly myocardial infarction; Immunohistochemistry; Sudden cardiac death; Systematic review; Animals; Biomarkers; Death Sudden Cardiac; Forensic Pathology; Humans; Immunohistochemistry; Myocardial Infarction; 2734Forensic PathologyPostmortem DiagnosisAnimalbusiness.industryEarly myocardial infarction Immunohistochemistry Sudden cardiac Death Systematic reviewBiomarkermedicine.diseaseImmunohistochemistrySudden cardiac deathDeath Sudden CardiacHeart failureInclusion and exclusion criteriaSystematic reviewImmunohistochemistrybusinessBiomarkersHumanInternational Journal of Legal Medicine
researchProduct

Sudden death in water: Diagnostic challenges

2016

Abstract The authors report a case of sudden death in a breath-holding diver and highlight the forensic diagnostic difficulties in opining the cause of sudden death in water. The autopsy showed increased thickness of the left ventricular wall with a distinct pattern of concentric hypertrophy, evident particularly in the subaortic interventricular septum. Histological examination revealed diffuse interstitial fibrosis and associated findings of multifocal myocyte disarray especially evident in the subaortic interventricular septum. The analysis and discussion of this case made it possible to attribute sudden death to a lethal arrhythmia following myocyte disarray and hypoxia caused by breath…

Pathologymedicine.medical_specialtyHealth (social science)2734Concentric hypertrophyAutopsy030204 cardiovascular system & hematologyBiologySudden deathPathology and Forensic Medicine03 medical and health sciences0302 clinical medicineSettore MED/43 - Medicina LegaleInternal medicinemedicinelcsh:Law in general. Comparative and uniform law. Jurisprudence030216 legal & forensic medicineInterventricular septumcardiovascular diseasesIncreased thicknessHypoxiaHistological examinationCause of deathlcsh:R5-920Sudden deathApneaArrhythmia; Breath-held diving; Hypoxia; Sudden death; 2734; Health (social science); Lawmedicine.anatomical_structurelcsh:K1-7720Cardiologycardiovascular systemBreath-held divingmedicine.symptomlcsh:Medicine (General)LawArrhythmia
researchProduct

Usefulness of DNA quantification in diagnosis of hypertrophic cardiomyopathies

2006

Hypertrophic cardiomyopathies (HCM) are a frequent cause of sudden death in both young people and adults. Different cardiomyopathies can be distinguished according to the etiological agent and, although there are morphological differences too, alterations in the quantity of DNA in the cardiomyocytes may play an important role in their pathogenesis and evolution. To understand the characteristics and the behaviour of the DNA index in hypertrophic cardiomyopathies, we have studied thirty cases (10 primaries or essential, 10 hypertensives and 10 toxic) and compared the results with those obtained for 10 macroscopically normal hearts. The results showed that the different cardiomyopathies were …

Pathologymedicine.medical_specialtyHeart diseasebusiness.industryHypertrophic cardiomyopathyCardiomyopathymedicine.diseaseSudden deathPathology and Forensic MedicineMuscle hypertrophyPathogenesismedicine.anatomical_structureVentriclemedicineDifferential diagnosisbusinessLawForensic Science International
researchProduct

Caspase 9 and Caspase 3 Immunohistochemical Pattern in Skeletal and Cardiac Muscles at Different Times after Death: An Experimental Study on PMI Esti…

2021

(1) Background: The estimation of the post mortem interval (PMI) is a challenge for forensic pathologists because data emerging from methods commonly applied are not always conclusive, since several conditions exist that may affect the reliability of these parameters. Thus, new approaches have been proposed to overcome such a limit. In recent years, several studies have been performed on proteins analyzing their expression/degradation patterns in relation to the progressing of the post mortem interval. (2) Methods: The immunoreactivity patterns of two apoptosis mediators—Caspase 9 and Caspase 3—have been tested in order to evaluate their potential role as markers of the post mortem interval…

Pathologymedicine.medical_specialtyMedicine (General)cardiac muscleforensic sciencesClinical BiochemistryCaspase 3Article03 medical and health sciences0302 clinical medicineR5-920caspase 3Medicine030216 legal & forensic medicineskeletal musclecaspase 9Caspase030304 developmental biologyPost-mortem intervalCaspase-90303 health sciencespost mortem intervalbiologybusiness.industryCardiac muscleSkeletal musclemedicine.anatomical_structureApoptosisbiology.proteinImmunohistochemistrybusinesstime after deathDiagnostics
researchProduct

Dystrophin and metalloproteinase 9 in myocardial ischemia: A post-mortem immunohistochemical study

2021

The presented study evaluated the expression of dystrophin and MMP-9 in cases of sudden cardiac death (SCD) due to coronary atherosclerotic disease (CAD) in order to analyze the characteristics and the chronology of their expression, providing evidence on the possible role in post-mortem diagnosis of myocardial ischemia. The expression of these proteins was also compared to C5b-9 complex and fibronectin expression to evaluate any differences. Two groups of CAD-related SCD, respectively group 1 with gross and/or histological evidence and group 2 with no specific histological signs of myocardial ischemia, were used. A third group formed by cases of acute mechanical asphyxiation was used as a …

Pathologymedicine.medical_specialtyMyocardial ischemiaMyocardial IschemiaCoronary Artery DiseasePathology and Forensic MedicineSudden cardiac deathDystrophin; Immunohistochemistry; MMP-9; Myocardial ischemia; Post-mortem analysis; Sudden cardiac deathDystrophinmedicineHumansMetalloproteinasebiologybusiness.industryMyocardiummedicine.diseaseImmunohistochemistryStainingFibronectinIssues ethics and legal aspectsMatrix Metalloproteinase 9biology.proteinImmunohistochemistryAntibodyDystrophinbusiness
researchProduct